VIEMED HEALTHCARE, INC. Income Statement
VMD|7 years of annual SEC 10-K data (FY2019-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 7 fiscal years. All figures from audited SEC 10-K filings.
VIEMED HEALTHCARE, INC. reported $183M in revenue and $10M in net income for FY2025. Revenue has grown at a 19.0% compound annual rate over the past 6 years.
Based on SEC 10-K filings.
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Revenue | $183.0M | $138.8M | $138.8M | $117.1M | $131.3M | $80.3M | $64.5M |
| Cost of Revenue | $70.2M | $54.2M | $54.2M | $43.7M | $51.2M | $24.3M | $16.7M |
| Gross Profit | $112.8M | $84.7M | $84.7M | $73.4M | $80.1M | $56.0M | $47.8M |
| SG&A Expense | $87.9M | $68.2M | $68.2M | $54.9M | $52.8M | $41.4M | $34.3M |
| R&D Expense | $2.8M | $2.7M | $2.7M | $2.1M | $1.1M | $848.0K | $0 |
| Operating Income | $14.3M | $8.3M | $8.3M | $11.6M | $26.8M | $8.9M | $10.1M |
| Income Tax | $4.1M | $2.8M | $2.8M | $3.4M | -$5.2M | $271.0K | $162.0K |
| Net Income | $10.2M | $6.2M | $6.2M | $9.1M | $31.5M | $8.5M | $9.5M |
| EPS (Basic) | $0.27 | $0.16 | $0.16 | $0.23 | $0.81 | $0.23 | $0.25 |
| EPS (Diluted) | $0.25 | $0.16 | $0.16 | $0.22 | $0.78 | $0.21 | $0.24 |
| Shares Outstanding | 39.1M | 38.5M | 38.0M | 40.7M | 39.2M | 38.0M | 37.5M |
| Gross Margin | 61.6% | 61.0% | 61.0% | 62.7% | 61.0% | 69.8% | 74.1% |
| Operating Margin | 7.8% | 5.9% | 5.9% | 9.9% | 20.4% | 11.0% | 15.6% |
| Profit Margin | 5.6% | 4.5% | 4.5% | 7.8% | 24.0% | 10.6% | 14.8% |